AllianThera emerges with Insilico deal, team of pharma vets

Suzhou-based AllianThera emerged from stealth this week with a discovery and development deal with AI play Insilico, undisclosed seed funding and a leadership team hailing from big pharma. 

The newco is led by long-time Pfizer Inc. (NYSE:PFE) veteran CEO Yuan-Hua Ding and CSO Javier Cote-Sierra, whose pedigree includes leadership roles at Sanofi (Euronext:SAN; NASDAQ:SNY), Pfizer and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). ...